2021
DOI: 10.29086/978-0-9869936-9-5/2021/aasbs07
|View full text |Cite
|
Sign up to set email alerts
|

Global Trends in Management, IT and Governance in an e-World (E-MIG 2019 International)

Abstract: PrefaceFor some years, the power of mobile technology has been accessible to everyone. Yet not many were making optimum use of it. COVID-19 has changed all that. With the implementation of lockdown and restriction of movement, globally, the importance of digital media has dawned on all. COVID-19 made us realise the importance of the E-World. Even those who had been either averse to e-learning or fearing to step into the e-universe had to embrace the technology to continue with their work, whether in business a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 151 publications
(235 reference statements)
0
1
0
Order By: Relevance
“…While the beneficial effects of combined treatment of anti-VEGF plus PRP has not been fully clarified in clinical trials, this approach appears to be a preferred practice pattern in the clinical practice setting. Yet, recent reporting from the American Society of Retina Specialists Preferences and Trends surveys revealed some clinician preference for anti-VEGF monotherapy in a select group of patients . However, limitations of anti-VEGF therapy have been reported, and ultimately, the treatment choice for PDR must be considered carefully based on the risks and benefits of each individual therapy and the patient’s values and compliance …”
Section: Discussionmentioning
confidence: 99%
“…While the beneficial effects of combined treatment of anti-VEGF plus PRP has not been fully clarified in clinical trials, this approach appears to be a preferred practice pattern in the clinical practice setting. Yet, recent reporting from the American Society of Retina Specialists Preferences and Trends surveys revealed some clinician preference for anti-VEGF monotherapy in a select group of patients . However, limitations of anti-VEGF therapy have been reported, and ultimately, the treatment choice for PDR must be considered carefully based on the risks and benefits of each individual therapy and the patient’s values and compliance …”
Section: Discussionmentioning
confidence: 99%